X0306 4 2019-04-26 0 0001737287 Allogene Therapeutics, Inc. ALLO 0001296549 Belldegrun Arie 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2019-04-26 4 J 0 598937 0.00 D 5390415 I See footnote Common Stock 2019-04-26 4 J 0 13413 0.00 A 501663 I See footnote Common Stock 150333 D Common Stock 3710006 I See footnote Common Stock 1691781 I See footnote Pro rata distribution of shares of the Issuer's common stock from VVAG Special Fund LLC (VVAG) to its members pursuant to a Rule 10b5-1 trading plan adopted by VVAG on March 29, 2019. The securities are held by VVAG, of which VVAG LLC is the manager. The reporting person is a Senior Managing Director of VVAG LLC and may therefore be deemed to be the beneficial owner of the common shares held by VVAG. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. The shares were received in the pro rata distribution from VVAG described above. The securities are held in the name of Bellco Capital, LLC, of which the reporting person is the manager. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The securities are held in the name of the Belldegrun Family Trust. The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. The reporting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. /s/ Veer Bhavnagri, Attorney-in-Fact 2019-04-30